Abstract
Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.
Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.
Current Stem Cell Research & Therapy
Title:Recent Advances in Treatment of Retinitis Pigmentosa
Volume: 10 Issue: 3
Author(s): Yuxi He, Yan Zhang and Guanfang Su
Affiliation:
Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.
Abstract: Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.
Export Options
About this article
Cite this article as:
He Yuxi, Zhang Yan and Su Guanfang, Recent Advances in Treatment of Retinitis Pigmentosa, Current Stem Cell Research & Therapy 2015; 10 (3) . https://dx.doi.org/10.2174/1574888X09666141027103552
DOI https://dx.doi.org/10.2174/1574888X09666141027103552 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents on Rho Signaling Pathway as Therapeutic Target for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism High-throughput Genotyping Methods for Pharmacogenomic Studies
Current Pharmacogenomics Evaluation of the Anti-Inflammatory Activities of Diclofenac Sodium, Prednisolone and Atorvastatin in Combination with Ascorbic Acid
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Contribution of Ultrasonography of Hands and Wrists in Early Rheumatoid Arthritis
Current Rheumatology Reviews Recent Advances in Controlled Release Pulmonary Therapy
Current Drug Delivery Chondroitin Sulphate for the Treatment of Osteoarthritis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Endogenous Factors in the Recovery of Reproductive Function After Testicular Injury and Cancer
Current Molecular Medicine Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design The Impact of Polyphenolics in the Management of Breast Cancer: Mechanistic Aspects and Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Anxiolytic and Antidepressant-like Effects of Monoterpene Tetrahydrolinalool and <i>In silico</i> Approach of new Potential Targets
Current Topics in Medicinal Chemistry Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis
Current Medicinal Chemistry Rheb/mTOR Activation and Regulation in Cancer: Novel Treatment Strategies beyond Rapamycin
Current Drug Targets Therapeutic Efficacy of Polyherbal Formulation Kabasura kudineer Against Common Viral Fevers - A Perspective Review
Anti-Infective Agents Pharmacokinetic Considerations of Perinatal Antiretroviral Therapy
Current Drug Metabolism A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer’s Disease
Current Clinical Pharmacology Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System?
Current Pharmaceutical Design Peculiarities of the Anticoagulant Properties for the Newly Synthesized Preparations of Coumarin-Related Compounds
Cardiovascular & Hematological Disorders-Drug Targets Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy
Mini-Reviews in Medicinal Chemistry